NCT07153458

Brief Summary

The study in question is an observational study that aims to identify new non-invasive biomarkers present in the serum of patients with CRC and, subsequently, to create a score capable of predicting the development of CRC. It is an observational study with 3 enrollment arms: Arm 1: Patients undergoing surgery at the U.O.C. of Surgery, with a CRC diagnosis; Arm 2: Subjects with a negative result from the endoscopic examination; Arm 3: Subjects in whom the presence of an adenoma with high-grade dysplasia is found, a condition considered pre-cancerous.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
19mo left

Started Dec 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Dec 2025Dec 2027

First Submitted

Initial submission to the registry

August 5, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 4, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

December 1, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

December 19, 2025

Status Verified

December 1, 2025

Enrollment Period

1 year

First QC Date

August 5, 2025

Last Update Submit

December 12, 2025

Conditions

Keywords

crc (colorectal cancer)Adenoma colonBiomarkersneoplasm

Outcome Measures

Primary Outcomes (1)

  • Variation in serum biomarkers for CRC

    Changes in the concentration of potential serum CRC biomarkers in patients with established CRC pre- and post-surgery, patients with an adenoma with high-grade dysplasia, and subjects with no evidence of disease.

    From enrollment to the day of the visit after 20 days

Secondary Outcomes (1)

  • Variation of macroconstituents

    From enrollment to the day of the visit after 20 days

Study Arms (3)

Patients undergoing surgery at the Department of Surgery, with a diagnosis of CRC;

Patients undergoing surgery at the Department of Surgery, with a diagnosis of CRC;

Subjects with a negative endoscopic examination result.

Subjects who attend our Institution's Department of Digestive Endoscopy for a colonoscopy performed for diagnostic purposes, with a negative endoscopic examination result.

Subjects with a diagnosis of adenoma with high-grade dysplasia, a condition considered pre-cancerous

Subjects who attend our Institution's Department of Digestive Endoscopy for a colonoscopy performed for diagnostic purposes, or patients undergoing a surgical procedure at the Department of Surgery, in whom the presence of an adenoma with high-grade dysplasia is found, a condition considered pre-cancerous.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study cohort is comprised of patients with a diagnosis of CRC who underwent surgical intervention, and a cohort of subjects with high-grade dysplasia adenoma, which is considered a precancerous condition.

You may qualify if:

  • AIM 1: Patients undergoing surgery at the U.O.C. of Surgery, with a diagnosis of CRC.
  • AIM 2: Subjects without colon disease.
  • AIM 3: Subjects with adenoma and high-grade dysplasia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Biobank Core Facility

Castellana Grotte, 70013, Italy

RECRUITING

Related Publications (3)

  • Martin-Garcia D, Garcia-Aranda M, Redondo M. Biomarker Identification through Proteomics in Colorectal Cancer. Int J Mol Sci. 2024 Feb 14;25(4):2283. doi: 10.3390/ijms25042283.

    PMID: 38396959BACKGROUND
  • Shah SC, Itzkowitz SH. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management. Gastroenterology. 2022 Mar;162(3):715-730.e3. doi: 10.1053/j.gastro.2021.10.035. Epub 2021 Oct 29.

    PMID: 34757143BACKGROUND
  • Sninsky JA, Shore BM, Lupu GV, Crockett SD. Risk Factors for Colorectal Polyps and Cancer. Gastrointest Endosc Clin N Am. 2022 Apr;32(2):195-213. doi: 10.1016/j.giec.2021.12.008. Epub 2022 Feb 22.

    PMID: 35361331BACKGROUND

MeSH Terms

Conditions

Colorectal NeoplasmsColonic NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Central Study Contacts

Pasqua Letizia Pesole, Biologist

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 5, 2025

First Posted

September 4, 2025

Study Start

December 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

December 19, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations